Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +36.41%
#3 Cysic Cysic +17.50%
#4 Bedrock Bedrock +11.95%
#5 Fabric Protocol Fabric Protocol +8.04%
#6 stake.link stake.link +7.65%
#7 Cap Cap +6.89%
#8 DUSK Network DUSK Network +5.71%
#9 Pons Pons +5.51%
#10 FOLKS FOLKS +5.24%
Coin of the day
EXOD EXOD
설정
언어
한국어
통화
USD
테마
Anatara Lifesciences Ltd Anatara Lifesciences Ltd

Anatara Lifesciences Ltd

ANR
주식 순위 #37961
Anatara Lifesciences Ltd is an Australian enterprise focused on researching,... Anatara Lifesciences Ltd is an Australian enterprise focused on researching, developing, and commercializing scientifically-validated therapies for digestive system ailments affecting both humans and animals. Its product portfolio includes Gastrointestinal ReProgramming (GRP), a proprietary blend combining bromelain with other evidence-based ingredients, specifically formulated to target the underlying issues of human gastrointestinal conditions such as irritable bowel syndrome and inflammatory bowel disease. The firm also offers 3FDC, designed to address anxiety, stress, or depression. In the animal health sector, Anatara provides Detach for treating diarrhea in piglets, BONIFF as an enhanced dry feed formulation for weaned piglets, and ANR-pf, a unique additive for poultry drinking water. This company was founded in 2010 and is headquartered in Carlton, Australia.
주가
$0.00634756
마지막 동기화: 2026-08-14
시가총액
$1.32M
변동 (1일)
0.00%
변동 (1년)
39.40%
국가
AU
거래 Anatara Lifesciences Ltd (ANR)

카테고리

Healthcare
Anatara Lifesciences Ltd (ANR)의 수익
2026 기준 수익 TTM: 0
Anatara Lifesciences Ltd의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Anatara Lifesciences Ltd의 수익 기록 (2026 ~ 2026)
연말 수익
연도 수익 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE